Fastplex BCR-ABL (p210) %IS Digital PCR Kit

High-precision digital PCR assay kit for quantifying BCR-ABL(p210) to support monitoring and management of chronic myeloid leukemia patients.

Real-time PCR kit for quantitative detection and monitoring of BCR-ABL1 fusion transcript in chronic myeloid leukemia. Enables precise measurement of disease burden and treatment response assessment.

A diagnostic test kit for quantitative measurement of BCR-ABL fusion transcripts. This kit provides absolute quantification of BCR-ABL1 levels for disease monitoring and therapeutic response assessment in chronic myeloid leukemia.

A diagnostic test kit for qualitative detection of BCR-ABL fusion transcripts. This kit enables detection of BCR-ABL1 presence for initial diagnosis of chronic myeloid leukemia.

A diagnostic test kit for screening and detection of BCR-ABL1 fusion transcripts. This kit is designed for initial identification of BCR-ABL1 in suspected chronic myeloid leukemia cases.

A diagnostic test kit for differentiation of BCR-ABL1 fusion transcript variants b2a2 and b3a2. This kit enables identification of specific BCR-ABL1 breakpoint variants relevant to chronic myeloid leukemia diagnosis.

A diagnostic test kit for differentiation of BCR-ABL1 transcript variants. This kit enables classification of BCR-ABL1 breakpoint types relevant to chronic myeloid leukemia characterization.

A diagnostic test kit for detection of BCR-ABL1 with EAC-DEL variant status. This kit identifies specific BCR-ABL1 deletion variants relevant to chronic myeloid leukemia diagnosis and prognosis.

Molecular diagnostic kit for screening leukemia-associated fusion genes using nucleic acid analysis. Enables detection of chromosomal abnormalities in blood and bone marrow samples to support leukemia diagnosis and classification. Utilizes advanced molecular techniques to identify clinically relevant fusion gene targets.

Real-time PCR assay for quantifying PML-RARA fusion transcript in acute promyelocytic leukemia. Enables monitoring of minimal residual disease during ATRA and arsenic trioxide therapy.

A diagnostic kit for detecting FGFR gene fusions using the MODAPLEX platform. Supports multi-biomarker testing for solid tumor profiling.

Targeted diagnostic panel for detecting mutations and fusion genes in acute lymphoblastic leukemia. Supports prognostic stratification and identification of therapeutic targets.